Zobrazeno 1 - 10
of 471
pro vyhledávání: '"Scott, Wright"'
Autor:
Jonathon W. Senefeld, PhD, Ellen K. Gorman, BS, Patrick W. Johnson, BS, M. Erin Moir, PhD, Stephen A. Klassen, PhD, Rickey E. Carter, PhD, Nigel S. Paneth, MD, David J. Sullivan, MD, Olaf H. Morkeberg, BA, R. Scott Wright, MD, DeLisa Fairweather, PhD, Katelyn A. Bruno, PhD, Shmuel Shoham, MD, Evan M. Bloch, MBChB, MS, Daniele Focosi, MD, Jeffrey P. Henderson, MD, PhD, Justin E. Juskewitch, MD, PhD, Liise-Anne Pirofski, MD, Brenda J. Grossman, MD, MPH, Aaron A.R. Tobian, MD, PhD, Massimo Franchini, MD, Ravindra Ganesh, MBBS, MD, Ryan T. Hurt, MD, PhD, Neil E. Kay, MD, Sameer A. Parikh, MBBS, Sarah E. Baker, PhD, Zachary A. Buchholtz, BS, Matthew R. Buras, BS, Andrew J. Clayburn, BS, Joshua J. Dennis, BS, Juan C. Diaz Soto, MD, Vitaly Herasevich, MD, PhD, Allan M. Klompas, MB, BCh, BAO, Katie L. Kunze, PhD, Kathryn F. Larson, MD, John R. Mills, PhD, Riley J. Regimbal, BS, Juan G. Ripoll, MD, Matthew A. Sexton, MD, John R.A. Shepherd, MD, James R. Stubbs, MD, Elitza S. Theel, PhD, Camille M. van Buskirk, MD, Noud van Helmond, MD, Matthew N.P. Vogt, MD, Emily R. Whelan, BS, Chad C. Wiggins, PhD, Jeffrey L. Winters, MD, Arturo Casadevall, MD, PhD, Michael J. Joyner, MD
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 7, Iss 5, Pp 499-513 (2023)
Objective: To examine the association of COVID-19 convalescent plasma transfusion with mortality and the differences between subgroups in hospitalized patients with COVID-19. Patients and Methods: On October 26, 2022, a systematic search was performe
Externí odkaz:
https://doaj.org/article/dadeeaf646b74fc8991c25a417a35f18
Publikováno v:
BMC Medical Education, Vol 23, Iss 1, Pp 1-8 (2023)
Abstract Introduction Imposter phenomenon is common among medical trainees and may influence learning and professional development. The authors sought to describe imposter phenomenon among internal medicine residents. Methods In 2020, using emailed i
Externí odkaz:
https://doaj.org/article/27ce04a760b543ac89f84ea6e1c91b67
Autor:
Ray, Kausik K *, Troquay, Roel P T, Visseren, Frank L J, Leiter, Lawrence A, Scott Wright, R, Vikarunnessa, Sheikh, Talloczy, Zsolt, Zang, Xiao, Maheux, Pierre, Lesogor, Anastasia, Landmesser, Ulf
Publikováno v:
In The Lancet Diabetes & Endocrinology February 2023 11(2):109-119
Autor:
Wolfgang Koenig, Kausik K. Ray, Ulf Landmesser, Lawrence A. Leiter, Gregory G. Schwartz, R. Scott Wright, Lorena Garcia Conde, Jackie Han, Frederick J. Raal
Publikováno v:
American Journal of Preventive Cardiology, Vol 14, Iss , Pp 100503- (2023)
Patients with cerebrovascular disease (CeVD) have been shown to benefit from lipid-lowering therapies, but guideline-recommended levels of low-density lipoprotein cholesterol (LDL-C) are often not attained with statin treatment alone. The ORION-9, OR
Externí odkaz:
https://doaj.org/article/17972f0d39ca43feb599af064db33e6b
Autor:
Lawrence A Leiter, David G Kallend, Wolfgang Koenig, Ulf Landmesser, Kausik K Ray, Gregory G Schwartz, R Scott Wright, YannTong Chiang, Lorena Garcia Conde Orozco, Frederick J Raal
Publikováno v:
American Journal of Preventive Cardiology, Vol 13, Iss , Pp 100403- (2023)
Therapeutic Area: ASCVD/CVD Risk Factors Background: Excessive bodyweight, often associated with dyslipidemia, may affect the pharmacology of drugs. Inclisiran, a small interfering RNA targeting PCSK9 hepatic mRNA, is an effective LDL-C lowering agen
Externí odkaz:
https://doaj.org/article/0011f94e522840b59e2bf9b7e51e40ab
Autor:
Katie L. Kunze, Patrick W. Johnson, Noud van Helmond, Jonathon W. Senefeld, Molly M. Petersen, Stephen A. Klassen, Chad C. Wiggins, Allan M. Klompas, Katelyn A. Bruno, John R. Mills, Elitza S. Theel, Matthew R. Buras, Michael A. Golafshar, Matthew A. Sexton, Juan C. Diaz Soto, Sarah E. Baker, John R. A. Shepherd, Nicole C. Verdun, Peter Marks, Nigel S. Paneth, DeLisa Fairweather, R. Scott Wright, Camille M. van Buskirk, Jeffrey L. Winters, James R. Stubbs, Katherine A. Senese, Michaela C. Pletsch, Zachary A. Buchholtz, Robert F. Rea, Vitaly Herasevich, Emily R. Whelan, Andrew J. Clayburn, Kathryn F. Larson, Juan G. Ripoll, Kylie J. Andersen, Elizabeth R. Lesser, Matthew N. P. Vogt, Joshua J. Dennis, Riley J. Regimbal, Philippe R. Bauer, Janis E. Blair, Arturo Casadevall, Rickey E. Carter, Michael J. Joyner
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-6 (2021)
Regional differences in SARS-CoV-2 variants may affect treatment outcome. Here, the authors show that near-sourced convalescent plasma has higher efficacy, as defined by death within 30 days of transfusion, than plasma sourced more than 150 miles awa
Externí odkaz:
https://doaj.org/article/b4c2e18825314c909846a2c6aed3901d
Autor:
Jennifer Brennan, Lalit Jain, Sofia Garman, Ann E Donnelly, Erik Scott Wright, Kevin Jamieson
Publikováno v:
PLoS Computational Biology, Vol 18, Iss 7, p e1010311 (2022)
Antibiotic resistance is an important public health problem. One potential solution is the development of synergistic antibiotic combinations, in which the combination is more effective than the component drugs. However, experimental progress in this
Externí odkaz:
https://doaj.org/article/ea7137edadf649d484822793f5c4a527
Autor:
Tengfei Ma, Chad C. Wiggins, Breanna M. Kornatowski, Ra'ed S. Hailat, Andrew J. Clayburn, Winston L. Guo, Patrick W. Johnson, Jonathon W. Senefeld, Stephen A. Klassen, Sarah E. Baker, Katelyn A. Bruno, DeLisa Fairweather, R. Scott Wright, Rickey E. Carter, Chenxi Li, Michael J. Joyner, Nigel S. Paneth
Publikováno v:
Frontiers in Medicine, Vol 8 (2022)
Treatment of patients with COVID-19 using convalescent plasma from recently recovered patients has been shown to be safe, but the time course of change in clinical status following plasma transfusion in relation to baseline disease severity has not y
Externí odkaz:
https://doaj.org/article/8809e7c2f31346c18a6dfe4062f3292a
Autor:
Jonathon W Senefeld, Patrick W Johnson, Katie L Kunze, Evan M Bloch, Noud van Helmond, Michael A Golafshar, Stephen A Klassen, Allan M Klompas, Matthew A Sexton, Juan C Diaz Soto, Brenda J Grossman, Aaron A R Tobian, Ruchika Goel, Chad C Wiggins, Katelyn A Bruno, Camille M van Buskirk, James R Stubbs, Jeffrey L Winters, Arturo Casadevall, Nigel S Paneth, Beth H Shaz, Molly M Petersen, Bruce S Sachais, Matthew R Buras, Mikolaj A Wieczorek, Benjamin Russoniello, Larry J Dumont, Sarah E Baker, Ralph R Vassallo, John R A Shepherd, Pampee P Young, Nicole C Verdun, Peter Marks, N Rebecca Haley, Robert F Rea, Louis Katz, Vitaly Herasevich, Dan A Waxman, Emily R Whelan, Aviv Bergman, Andrew J Clayburn, Mary Kathryn Grabowski, Kathryn F Larson, Juan G Ripoll, Kylie J Andersen, Matthew N P Vogt, Joshua J Dennis, Riley J Regimbal, Philippe R Bauer, Janis E Blair, Zachary A Buchholtz, Michaela C Pletsch, Katherine Wright, Joel T Greenshields, Michael J Joyner, R Scott Wright, Rickey E Carter, DeLisa Fairweather
Publikováno v:
PLoS Medicine, Vol 18, Iss 12, p e1003872 (2021)
BackgroundThe United States (US) Expanded Access Program (EAP) to coronavirus disease 2019 (COVID-19) convalescent plasma was initiated in response to the rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative age
Externí odkaz:
https://doaj.org/article/b6326af583c74bfba59628eb0bc601dc
Autor:
Stephen A. Klassen, Jonathon W. Senefeld, Katherine A. Senese, Patrick W. Johnson, Chad C. Wiggins, Sarah E. Baker, Noud van Helmond, Katelyn A. Bruno, Liise-anne Pirofski, Shmuel Shoham, Brenda J. Grossman, Jeffrey P. Henderson, R. Scott Wright, DeLisa Fairweather, Nigel S. Paneth, Rickey E. Carter, Arturo Casadevall, Michael J. Joyner
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Convalescent plasma has been used worldwide to treat patients hospitalized with coronavirus disease 2019 (COVID-19) and prevent disease progression. Despite global usage, uncertainty remains regarding plasma efficacy, as randomized controlled trials
Externí odkaz:
https://doaj.org/article/2fb963ecbc8a4dfe8feeb144e3c1de30